Ionis Pharmaceuticals Inc’s recent filing unveils that its Director Hayden Michael R acquired Company’s shares for reported $0.48 million on May 01 ’25. In the deal valued at $31.86 per share,15,000 shares were bought. As a result of this transaction, Hayden Michael R now holds 50,219 shares worth roughly $2.1 million.
Then, Birchler Brian sold 680 shares, generating $19,292 in total proceeds. Upon selling the shares at $28.37, the EVP, Corp and Development Ops now owns 56,660 shares.
Before that, Jenne Kyle sold 3,016 shares. Ionis Pharmaceuticals Inc shares valued at $85,534 were divested by the EVP, Chf GL Pdt Str Ofcr at a price of $28.36 per share. As a result of the transaction, Jenne Kyle now holds 11,199 shares, worth roughly $0.47 million.
Barclays upgraded its Ionis Pharmaceuticals Inc [IONS] rating to an Overweight from a an Equal weight in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Redburn Atlantic began covering IONS with “Neutral” recommendation on March 31, 2025. BMO Capital Markets revised its rating on August 02, 2024. It rated IONS as “a Market perform” which previously was an “an Outperform”.
Price Performance Review of IONS
On Friday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock fall -1.53% to $41.73. Over the last five days, the stock has lost -2.95%. Ionis Pharmaceuticals Inc shares have fallen nearly -11.29% since the year began. Nevertheless, the stocks have risen 19.36% over the past one year. While a 52-week high of $52.34 was reached on 07/02/25, a 52-week low of $23.95 was recorded on 04/09/25.
Levels Of Support And Resistance For IONS Stock
The 24-hour chart illustrates a support level at 41.39, which if violated will result in even more drops to 41.05. On the upside, there is a resistance level at 42.13. A further resistance level may holdings at 42.53.
How much short interest is there in Ionis Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ionis Pharmaceuticals Inc stocks on 2025-06-13, dropping by -1.04 million shares to a total of 14.23 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 15.27 million shares. There was a decline of -7.31%, which implies that there is a negative sentiment for the stock.
